1 / 10

Migraine Drugs Market Expected to Reach $2,190 Million, Globally, by 2025

The market was valued at $1,713 million in 2017, and is expected to reach $2,190 million by 2025, growing at a CAGR of 3.1% from 2018 to 2025. North America is anticipated to be the highest revenue contributor throughout the forecast period.

Abhi711
Download Presentation

Migraine Drugs Market Expected to Reach $2,190 Million, Globally, by 2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Opportunity Analysis and Industry Forecast, 2016-2023

  2. Introductionof Migraine Drugs Market The market was valued at $1,713 million in 2017, and is expected to reach $2,190 million by 2025, growing at a CAGR of 3.1% from 2018 to 2025. North America is anticipated to be the highest revenue contributor throughout the forecast period. Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea, and even disturbed vision in some cases. Increase in prevalence of migraine, rapid rise in female population, and surge in awareness among patients for migraine treatment & prevention drive the growth of the global migraine drugs market. However, side effects of migraine drugs are expected to limit the market growth. Conversely, emerging new therapies/drugs for migraine treatment and growth opportunities in the emerging nations are expected to present opportunities for the market growth during the forecast period.

  3. Introductionof Migraine Drugs Market Scopeof theReport KeyBenefits KeyAudiences

  4. Key Benefits • North America occupied two-fifths share of the global migraine drugs market. • Oral is anticipated to grow with the highest CAGR throughout the forecast period. • Europe is anticipated to occupy more than one-fourth market share of the global migraine drugs market by 2025. • Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.

  5. Table of Content (TOC) Chapter: 1 Introduction Chapter: 2 Executive Summary Chapter: 3 Market Overview Chapter: 4: Migraine Drugs Market, By Type Chapter: 5: Migraine Drugs Market, By Route Of Administration Chapter: 6: Migraine Drugs Market, By Distribution Channel Chapter: 7: Migraine Drugs Market, By Region Chapter: 8: Company Profiles

  6. Segments Migraine Drugs Market

  7. Segments Migraine Drugs Market

  8. Segments Migraine Drugs Market

  9. Company Profiles Migraine Drugs Market Abbott Laboratories AbbVie Inc. Allergan Plc. AstraZeneca PLC Eisai Co., Ltd. Endo International Plc.

  10. Thank You Migraine Drugs Market ThankYou! For MoreDetails Do Enquiry https://www.alliedmarketresearch.com/migraine-drugs-market Follow UsOn

More Related